Grace & White Inc’s Novo Nordisk NVO Stock Holding History

Grace & White Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1M	Hold	29,000	–	–	0.18%	84
2026 Q2	$1.39M	Hold	29,000	–	–	0.22%	78
2026 Q1	$1.07M	Hold	29,000	–	–	0.19%	86
2025 Q4	$1.48M	Hold	29,000	–	–	0.26%	75
2025 Q3	$1.61M	Hold	29,000	–	–	0.28%	74
2025 Q2	$2M	Hold	29,000	–	–	0.37%	65
2025 Q1	$2.01M	Hold	29,000	–	–	0.38%	62
2024 Q4	$2.49M	Hold	29,000	–	–	0.47%	56
2024 Q3	$3.45M	Hold	29,000	–	–	0.62%	43
2024 Q2	$4.14M	Sell	29,000 -4,000	-12%	-$530K	0.78%	39
2024 Q1	$4.24M	Hold	33,000	–	–	0.76%	38
2023 Q4	$3.41M	Hold	33,000	–	–	0.6%	52
2023 Q3	$3M	Hold	33,000	–	–	0.56%	54
2023 Q2	$2.67M	Buy	33,000 +22,000	+200%	+$1.8M	0.49%	56
2023 Q1	$875K	Buy	+11,000	New	+$780K	0.17%	89

Other funds holding NVO

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Grace & White Inc's NVO Position: Q3 2026 in Review

Grace & White Inc held its Novo Nordisk (NVO) position steady in Q3 2026 at 29,000 shares worth $1.1M. The position accounts for 0.18% of the portfolio, ranked #84.

Grace & White Inc first reported a position in NVO in Q1 2023 and has held it in 15 quarters since. The position peaked at $4.24M in Q1 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Grace & White Inc held 29,000 shares of Novo Nordisk worth $1.1M as of Q3 2026.
Grace & White Inc left its Novo Nordisk share count unchanged in Q3 2026.
Novo Nordisk made up 0.18% of Grace & White Inc's portfolio in Q3 2026, its #84 holding.
Grace & White Inc first reported a position in Novo Nordisk in Q1 2023 and has held it in 15 quarters since.
Grace & White Inc's Novo Nordisk position peaked at $4.24M in Q1 2024.
1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Grace & White Inc's 13F filing for Q3 2026, filed 23 Oct 2026.